Maintaining such a level of immunosuppression is associated with a carcinological risk. Thus, the use of thiopurines is clearly associated with a risk of developing lymphoma [
13]. In 2011, 43 cases of lymphoma were described among the 16,023 patients treated with immunosuppressants for IBD [
13]. The type of lymphoma most often diagnosed was large cell B lymphoma (44%), then
follicular lymphoma(14%) then
Hodgkin's lymphoma (12%).
In addition, the use of azathioprine or 6-mercaptopurine increased the risk of developing lymphoma by 4–5. On the other hand, the correlation between the occurrence of lymphoma and the use of an anti
TNF is more disputed due to the use, often in parallel, of anti TNF and thiopurines in most patients [
14]. A meta-analysis of 26 studies had described 13 cases of non-Hodgkin's lymphoma in adults treated with anti TNF for CD. Compared to the risk in the general population of developing lymphoma (1.9 per 10,000 person-years), the risk under anti TNF therapy was 3 times higher (3.2 per 10,000 person-years). Nevertheless, among the cases, 66% were also on thiopurines at the time of the diagnosis of lymphoma.
Finally, the TREAT study [
15] is the only prospective study that continues to compare the side effects of
infliximab with those of other therapies in more than 6000 patients treated for CD since 1999. The last update of this study in 2014 did not report any correlation between the use of infliximab and the risk of neoplasia but confirmed that immunosuppressive treatments, alone or in combination with biotherapies, increased the carcinogenic risk with odds with respective ratios of 4.19 and 3.33.
Similarly, Herrinton et al. reported that combotherapy increased the risk of developing lymphoma by a factor of 6 compared to the risk of the general population [
13].
Non-Hodgkin's lymphomas can be complicated by
intestinal perforation, especially after the initiation of anti-tumor chemotherapy, but the perforations can complicate the natural history of a lymphoma. These perforations most often occur in the small intestine and generally require emergency surgery [
16]. Perforation is also known as a rare acute surgical emergency complicating the natural history of the CD, occurring in 1–3% of cases [
17]. However, in other cases, perforation of a cancer, endoscopic perforation or anastomotic failure may occur.